|
Generic Name : Cladribine
Pronunciation : KLAD-ri-been
Therapeutic Classification : Chemotherapy
Trade Name(s):
International- Leustatin. When it is not to be taken (Contraindications): Hypersensitivity.
When it is to be taken : IV- The recommended dose is a single course given by continuous infusion for 7 consecutive days at a dose of 0.09 mg/kg/day. How it should be taken : It comes as a solution for injection to be administered by a healthcare provider into the vein. Special Instruction : * Caution should be exercised in patients with history of liver or kidney disease, any allergy, who are taking other medications, elderly, children, during pregnancy and breast-feeding. * It may cause dizziness, do not drive a car or operate machinery while taking this medication. * It may reduce platelet counts; avoid injury or bruising. * Avoid contact with people who have infections. Side Effects : Most Common - Fatigue, nausea, and injection site reactions. Body as a Whole - Fever, fatigue, chills, weakness, increased sweating, uneasiness and trunk pain. Gastrointestinal - Nausea, decreased appetite, vomiting, diarrhea, constipation and abdominal pain. Blood - Bruising and nose bleed. Central Nervous System - Headache, dizziness and sleeplessness. Heart - Fast heart rate and fluid retention. Respiratory - Abnormal breath sounds, cough, abnormal chest sounds and shortness of breath. Skin - Rash, itching, pain and redness. Musculoskeletal - Muscle pain and joint pain. * Avoid excess dosage. Storage Conditions : Store this medication as directed by your physician. |
![]() Comment & Contribute
![]()
![]() ![]() | ||


